Improving the use of research evidence in guideline development: 4. Managing conflicts of interests

Health Research Policy and Systems

Volumn 4, Issue , 2006, Pages

  Boyd, Elizabeth A ^a   Bero, Lisa A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT OF INTEREST; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; MEDLINE; PRACTICE GUIDELINE; REVIEW; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION;

EID: 33845264960     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-4-16     Document Type: Review

References (53)

1. Barnes DE, Bero LA: Why review articles an the health effects of passive smoking reach different conclusions. Jama 1998, 279(19):1566-1570.
2. Barnes DE, Bero LA: Scientific quality of original research articles on environmental tobacco smoke. Tob Control 1997, 6(1):19-26.
3. Bekelman JE, Li Y, Gross CP: Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 2003, 289(454-65):.
4. Cho MK, Bero LA: The quality of drug studies published in symposium proceedings. Ann Intern Med 1996, 124(5):485-489.
5. Lexchin J, Bero LA, Djulbegovic B, Clark O: Pharmaceutical Industry sponsorship and research outcome and quality: systematic review. Bmj 2003, 326(7400):1167-1170.
6. Wilson D, Heath D: He saw the tests as a violation of 'trusting desperate human beings'. In The Seattle Times Seattle; 2001.
7. Wilson D, Heath D: Uninformed consent: they call the place Mother Hutch. In The Seattle Times Seattle; 2001.
8. Dana J: Harm avoidance and financial conflict of interest. Journal of Medical Ethics 2003, Online Electronic Version: 1-18.
9. Bero LA: Tobacco industry manipulation of research. Public Health Rep in press.
10. Montori VM, Jaeschke R, Schunemann HJ, Bhandari M, Brozek JL, Devereaux PJ, Guyatt GH: Users' guide to detecting misleading claims in clinical research reports. BMJ 2004, 329:1093-1096.
11. Friedman PJ: The impact of conflict of interest on trust in science. Science and Engineering Ethics 2002, 8(3):413-420.
12. Drazen JM, Koski G: To protect those who serve [editorial]. The New England Journal of Medicine 2000, 343:1643-1645.
13. Baltimore D: The worsening climate for biological research; is the public losing faith in science? Technology Review 1989, 92(4):22.
14. Haerlin B, D. P: How to restore public trust in science [commentary]. Nature 1999, 400:499.
15. Cohen JJ: Trust us to make a difference: Ensuring public confidence in the integrity of clinical research. Academic Medicine 2001, 76(2):209-214.
16. DeAngelis CD: Conflict of interest and the public interest. Journal of the American Medical Association 2000, 284(17):2237-2238.
17. Fretheim A, Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 3. Group composition and consultation process. Health Research Policy and Systems 2006.
18. Fretheim A, Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 5. Group processes. Health Research Policy and Systems 2006.
19. World Health Organisation: Regulations for Expert Advisory Panels and Committees. 2003:101-109.
20. World Health Organisation: Global Programme on Evidence for Health Policy, Guidelines for WHO Guidelines. 2003:15.
21. World Health Organisation: Draft Guidelines for Declaration of Interest (WHO Experts). 2005.
22. Godlee F: Tobacco industry's smoke screen blown. The Scientist 2000.
23. World Health Organisation: WHO/ISH Hypertension Guidelines. 2003.
24. Oxman AD Fretheim A, Schünemann HJ: Improving the Use of Research Evidence in Guideline Development: Introduction. Health Res Policy Syst 2006.
25. Cochrane Methodology Register [http://www.cochrane.org/access_data/ cmr/accessDB_cmr.asp
26. Cochrane Collaboration: Cochrane Collaboration policy on commercial sponsorship. 2004.
27. National Institute for Clinical Excellence: Review of code of practice on declaration of conflicts of interest.
28. Draft guidance on disclosure of conflicts of interest for special government employees participating in FDA product special advisory committees. U.S. Food and Drug Administration; 2002.
29. Policies and procedures for handling conflicts of interest with FDA advisory committee members, consultants, and experts. U.S. Food and Drug Administration; 2005.
30. Policy on committee composition and balance and conflcits of interest for committees used in the development of reports. The National Academies; 2003.
31. Krimsky S: Science in the Private interest: Lanham, Maryland, Rowan & Littlefield; 2003:247.
32. Bero LA, Glantz S, Hong MK: The limits of competing interest disclosures. Tobacco Control 2005, 14:118-126.
33. Association of American Medical Colleges: Protecting subjects, preserving trust, promoting progress: Guidelines for developing and implementing a policy concerning individual financial interests in human subjects research. Philadelphia; 2001.
34. U.S. Department of Health and Human Services: Objectivity in research. Volume 35810 (codified at 42 CFR 50. 60 Federal Register; 1995.
35. Boyd E, Lipton S, Bero L: Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs 2004, 23(2):206-214.
36. Sprecker K: How involvement, citation style, and funding source affect the credibility of university scientists. Science Communication 2002, 24(1):72-97.
37. Kim SYH, et al.: Potential research participants' views regarding researcher and institutional financial conflicts of interest. Journal of Medical Ethics 2003. Online Electronic Version: p. 1-18
38. Glaser B, Bero L: Attitudes of Academic and Clinical Researchers toward Financial Ties in Research. Science and Engineering Ethics. 2005, 11:553-573.
39. Schroter S, Morris J, Chaudhry S, Smith RD, Barratt H: Does the type of competing interest statement affect readers' perceptions of the credibility of research? A randomized trial. BMJ 2004, 328:742-743.
40. Boyd EA Ph.D., Bero LA Ph.D.: Assessing Faculty Financial Relationships with industry. Journal of the American Medical Association 2000, 284(November 1, 2000):2209-2238.
41. Boyd EA, Cho MK, Bero LA: Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Academic Medicine 2003, 78(8):769-774.
42. Krimsky S Rothenberg, LS., Stott, P., Kyle, G.: Financial interests on authors in scientific journals: a principal investigator lot: study of 14 publications. Science and Engineering Ethics 1996, 2(4):395-410.
43. Shamoo AE, Resnik DB: Responsible Conduct of Research. New York, Oxford University Press; 2003:345.
44. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. International Committee of Medical Journal Editors; 2005. Available at: http://www.icmje.org
45. Krimsky S, Rothenberg LS: Conflict of interest policies in science and medical journals: Editorial practices and author disclosures. 2001, 7:205-218.
46. Gross CP, Gupta AR, Krumholz HM: Disclosure of financial competing interests in randomised controlled trials: cross sectional review. BMJ 2003, 326:526-527.
47. Choudhry NK, Stelfox HT, Detsky AS: Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002, 287(5):612-617.
48. Papanikolaou GN, Baltogianni MS, Contopoulos-Ioannidis DS, Haidich AB, Giannakakis IA, Ioannidis JPA: Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Medical Research Methodology 2001, 1(3):.
49. Jansen LA, Sulmasy DP: Bioethics, conflicts of interest, and the limits of transparency. Hastings Center Report 2003, 33:40-43.
50. Rothman K: Conflict of interest: The new McCarthyism in science. JAMA 1993, 269:2782-2784.
51. Duderstadt J: A university for the 21st century. Ann Arbor, University of Michigan Press; 2000.
52. Barnes D, Bero L: Why review articles on the health effects of passive smoking reach different conclusions. Journal of the American Medical Association 1998, 279:1566-1570.
53. Barnes D, Bero L: Scientific quality of original research articles on environmental tobacco smoke. Tobacco Control 1997, 6:19-26.